List of Tables
Table 1. Global General Medicines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global General Medicines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global General Medicines Market Competitive Situation by Manufacturers in 2024
Table 4. Global General Medicines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global General Medicines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global General Medicines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global General Medicines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market General Medicines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of General Medicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of General Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of General Medicines, Product Type & Application
Table 12. Global Key Manufacturers of General Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global General Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Medicines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global General Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global General Medicines Sales by Region (2020-2025) & (K Units)
Table 18. Global General Medicines Sales Market Share by Region (2020-2025)
Table 19. Global General Medicines Sales by Region (2026-2031) & (K Units)
Table 20. Global General Medicines Sales Market Share by Region (2026-2031)
Table 21. Global General Medicines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global General Medicines Revenue Market Share by Region (2020-2025)
Table 23. Global General Medicines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global General Medicines Revenue Market Share by Region (2026-2031)
Table 25. North America General Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America General Medicines Sales by Country (2020-2025) & (K Units)
Table 27. North America General Medicines Sales by Country (2026-2031) & (K Units)
Table 28. North America General Medicines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America General Medicines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe General Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe General Medicines Sales by Country (2020-2025) & (K Units)
Table 32. Europe General Medicines Sales by Country (2026-2031) & (K Units)
Table 33. Europe General Medicines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe General Medicines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific General Medicines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific General Medicines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific General Medicines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific General Medicines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific General Medicines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America General Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America General Medicines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America General Medicines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America General Medicines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America General Medicines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa General Medicines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa General Medicines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa General Medicines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa General Medicines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa General Medicines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global General Medicines Sales (K Units) by Type (2020-2025)
Table 51. Global General Medicines Sales (K Units) by Type (2026-2031)
Table 52. Global General Medicines Sales Market Share by Type (2020-2025)
Table 53. Global General Medicines Sales Market Share by Type (2026-2031)
Table 54. Global General Medicines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global General Medicines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global General Medicines Revenue Market Share by Type (2020-2025)
Table 57. Global General Medicines Revenue Market Share by Type (2026-2031)
Table 58. Global General Medicines Price (US$/Unit) by Type (2020-2025)
Table 59. Global General Medicines Price (US$/Unit) by Type (2026-2031)
Table 60. Global General Medicines Sales (K Units) by Application (2020-2025)
Table 61. Global General Medicines Sales (K Units) by Application (2026-2031)
Table 62. Global General Medicines Sales Market Share by Application (2020-2025)
Table 63. Global General Medicines Sales Market Share by Application (2026-2031)
Table 64. Global General Medicines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global General Medicines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global General Medicines Revenue Market Share by Application (2020-2025)
Table 67. Global General Medicines Revenue Market Share by Application (2026-2031)
Table 68. Global General Medicines Price (US$/Unit) by Application (2020-2025)
Table 69. Global General Medicines Price (US$/Unit) by Application (2026-2031)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Eli Lilly General Medicines Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Novo Nordisk Company Information
Table 76. Novo Nordisk Description and Business Overview
Table 77. Novo Nordisk General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Novo Nordisk General Medicines Product
Table 79. Novo Nordisk Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson General Medicines Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Merck General Medicines Product
Table 89. Merck Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AbbVie General Medicines Product
Table 94. AbbVie Recent Developments/Updates
Table 95. Roche Company Information
Table 96. Roche Description and Business Overview
Table 97. Roche General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Roche General Medicines Product
Table 99. Roche Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. AstraZeneca General Medicines Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Novartis Company Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Novartis General Medicines Product
Table 109. Novartis Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer General Medicines Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Amgen Company Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Amgen General Medicines Product
Table 119. Amgen Recent Developments/Updates
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi General Medicines Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Bristol-Myers Squibb General Medicines Product
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Gilead Sciences Company Information
Table 131. Gilead Sciences Description and Business Overview
Table 132. Gilead Sciences General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Gilead Sciences General Medicines Product
Table 134. Gilead Sciences Recent Developments/Updates
Table 135. Vertex Pharmaceuticals Company Information
Table 136. Vertex Pharmaceuticals Description and Business Overview
Table 137. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Vertex Pharmaceuticals General Medicines Product
Table 139. Vertex Pharmaceuticals Recent Developments/Updates
Table 140. CVS Health Company Information
Table 141. CVS Health Description and Business Overview
Table 142. CVS Health General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. CVS Health General Medicines Product
Table 144. CVS Health Recent Developments/Updates
Table 145. Regeneron Pharmaceuticals Company Information
Table 146. Regeneron Pharmaceuticals Description and Business Overview
Table 147. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Regeneron Pharmaceuticals General Medicines Product
Table 149. Regeneron Pharmaceuticals Recent Developments/Updates
Table 150. Zoetis Company Information
Table 151. Zoetis Description and Business Overview
Table 152. Zoetis General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Zoetis General Medicines Product
Table 154. Zoetis Recent Developments/Updates
Table 155. GlaxoSmithKline Company Information
Table 156. GlaxoSmithKline Description and Business Overview
Table 157. GlaxoSmithKline General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. GlaxoSmithKline General Medicines Product
Table 159. GlaxoSmithKline Recent Developments/Updates
Table 160. Daiichi Sankyō Company Information
Table 161. Daiichi Sankyō Description and Business Overview
Table 162. Daiichi Sankyō General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Daiichi Sankyō General Medicines Product
Table 164. Daiichi Sankyō Recent Developments/Updates
Table 165. Chugai Pharmaceutical Company Information
Table 166. Chugai Pharmaceutical Description and Business Overview
Table 167. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Chugai Pharmaceutical General Medicines Product
Table 169. Chugai Pharmaceutical Recent Developments/Updates
Table 170. Takeda Pharmaceutical Company Information
Table 171. Takeda Pharmaceutical Description and Business Overview
Table 172. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Takeda Pharmaceutical General Medicines Product
Table 174. Takeda Pharmaceutical Recent Developments/Updates
Table 175. Bayer Company Information
Table 176. Bayer Description and Business Overview
Table 177. Bayer General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Bayer General Medicines Product
Table 179. Bayer Recent Developments/Updates
Table 180. Seagen Company Information
Table 181. Seagen Description and Business Overview
Table 182. Seagen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Seagen General Medicines Product
Table 184. Seagen Recent Developments/Updates
Table 185. Jiangsu Hengrui Medicine Company Information
Table 186. Jiangsu Hengrui Medicine Description and Business Overview
Table 187. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Jiangsu Hengrui Medicine General Medicines Product
Table 189. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 190. Biogen Company Information
Table 191. Biogen Description and Business Overview
Table 192. Biogen General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Biogen General Medicines Product
Table 194. Biogen Recent Developments/Updates
Table 195. Moderna Company Information
Table 196. Moderna Description and Business Overview
Table 197. Moderna General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 198. Moderna General Medicines Product
Table 199. Moderna Recent Developments/Updates
Table 200. Lonza Company Information
Table 201. Lonza Description and Business Overview
Table 202. Lonza General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 203. Lonza General Medicines Product
Table 204. Lonza Recent Developments/Updates
Table 205. Sun Pharmaceutical Company Information
Table 206. Sun Pharmaceutical Description and Business Overview
Table 207. Sun Pharmaceutical General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 208. Sun Pharmaceutical General Medicines Product
Table 209. Sun Pharmaceutical Recent Developments/Updates
Table 210. Argenx Company Information
Table 211. Argenx Description and Business Overview
Table 212. Argenx General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 213. Argenx General Medicines Product
Table 214. Argenx Recent Developments/Updates
Table 215. Horizon Therapeutics Company Information
Table 216. Horizon Therapeutics Description and Business Overview
Table 217. Horizon Therapeutics General Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 218. Horizon Therapeutics General Medicines Product
Table 219. Horizon Therapeutics Recent Developments/Updates
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. General Medicines Distributors List
Table 223. General Medicines Customers List
Table 224. General Medicines Market Trends
Table 225. General Medicines Market Drivers
Table 226. General Medicines Market Challenges
Table 227. General Medicines Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
Table 231. Authors List of This Report
List of Figures
Figure 1. Product Picture of General Medicines
Figure 2. Global General Medicines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global General Medicines Market Share by Type: 2024 & 2031
Figure 4. Over-the-Counter (OTC) Product Picture
Figure 5. Prescription (Rx) Product Picture
Figure 6. Global General Medicines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global General Medicines Market Share by Application: 2024 & 2031
Figure 8. Antibiotics
Figure 9. Analgesics
Figure 10. Antipyretics
Figure 11. Antihypertensives
Figure 12. Antidiabetic Drugs
Figure 13. Others
Figure 14. Global General Medicines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global General Medicines Market Size (2020-2031) & (US$ Million)
Figure 16. Global General Medicines Sales (2020-2031) & (K Units)
Figure 17. Global General Medicines Average Price (US$/Unit) & (2020-2031)
Figure 18. General Medicines Report Years Considered
Figure 19. General Medicines Sales Share by Manufacturers in 2024
Figure 20. Global General Medicines Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest General Medicines Players: Market Share by Revenue in General Medicines in 2024
Figure 22. General Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global General Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America General Medicines Sales Market Share by Country (2020-2031)
Figure 25. North America General Medicines Revenue Market Share by Country (2020-2031)
Figure 26. United States General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe General Medicines Sales Market Share by Country (2020-2031)
Figure 29. Europe General Medicines Revenue Market Share by Country (2020-2031)
Figure 30. Germany General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific General Medicines Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific General Medicines Revenue Market Share by Region (2020-2031)
Figure 37. China General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America General Medicines Sales Market Share by Country (2020-2031)
Figure 45. Latin America General Medicines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa General Medicines Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa General Medicines Revenue Market Share by Country (2020-2031)
Figure 52. Turkey General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE General Medicines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of General Medicines by Type (2020-2031)
Figure 56. Global Revenue Market Share of General Medicines by Type (2020-2031)
Figure 57. Global General Medicines Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of General Medicines by Application (2020-2031)
Figure 59. Global Revenue Market Share of General Medicines by Application (2020-2031)
Figure 60. Global General Medicines Price (US$/Unit) by Application (2020-2031)
Figure 61. General Medicines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
